Hyaluronan suppresses fibronectin fragment-mediated damage to human cartilage explant cultures by enhancing proteoglycan synthesis

Journal of Orthopaedic Research

Volumn 17, Issue 6, 1999, Pages 858-869

  Kang, Yong ^a   Eger, Wolfgang ^a   Koepp, Holger ^a   Williams, James M ^a,b,c   Kuettner, Klaus E ^a   Homandberg, Gene A ^a,d  

^a Departments of Biochemistry   (United States)

^b Departments of Anatomy   (United States)

^c RUSH MEDICAL COLLEGE   (United States)

^d RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIODEGRADATION; BIOSYNTHESIS; ENZYMES; JOINTS (ANATOMY); MOLECULAR WEIGHT; POLYSACCHARIDES; TISSUE CULTURE;

HYALURONIC ACID;

CARTILAGE;

CYTOKINE; EPITOPE; FIBRONECTIN; HYALURONIC ACID; MATRIX METALLOPROTEINASE; PROTEOGLYCAN; STROMELYSIN;

ADOLESCENT; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARTILAGE DEGENERATION; CATTLE; CONTROLLED STUDY; DRUG EFFECT; EXPLANT; FEMALE; HUMAN; HUMAN TISSUE; KNEE INJURY; MALE; NONHUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEOGLYCAN SYNTHESIS; RABBIT;

EID: 0033378294     PISSN: 07360266     EISSN: None     Source Type: Journal    
DOI: 10.1002/jor.1100170611     Document Type: Article

References (33)

1. 1 Akatsuka M, Yamamoto Y, Tobetto K, Yasui T, Ando, T: In vitro effects of hyaluronan on prostaglandin E2 induction by interleukin‐1 in rabbit articular chondrocytes. Agents Actions 38: 122–125, 1993
2. 2 Bragantini A, Cassini M, De bastiani G, Perbellini A: Controlled single blind trial of intraarticularly injected hyaluronic acid (Hyalgan) in osteoarthritis of the knee. Clin Trials J 24: 333–340, 1987
3. 3 Dingle JT: Cartilage maintenance in osteoarthritis; interaction of cytokines, NSAID and prostaglandins in articular cartilage and repair. J Rheumatol 28 (Suppl): 30–37, 1991
4. 4 Forrester J, Balazs EA: Inhibition of phagocytosis by high molecular weight hyaluronate. Immunology 40: 435–446, 1980
5. 5 Fukuda K, Dan H, Takayama M, Kumano F, Saitoh M, Tanaka S: Hyaluronic acid increases proteoglycan synthesis in bovine articular cartilage in the presence of interleukin‐1. J Pharmacol Exp Ther 277: 1672–1675, 1996
6. 6 Fukuda K, Takayama M, Ueno M, Oh M, Asada S, Kumano F, Tanaka S: Hyaluronic acid inhibits interleukin‐1‐induced superoxide anion in bovine chondrocytes. Inflamm Res 46: 114–117, 1997
7. 7 Hakansson L, Hallgren R, Venge P: Regulation of granulocyte function by hyaluronic acid: in vitro and in vivo effect on phagocytosis, locomotion, and metabolism. J Clin Invest 66: 298–305, 1980
8. 8 Hollander AP, Atkins RM, Eastwood DM, Dieppe PA, Elson CJ: Human cartilage is degraded by rheumatoid arthritis synovial fluid but not by recombinant cytokines in vitro. Clin Exp Immunol 83: 52–57, 1991
9. 9 Homandberg GA, Meyers R, Xie DL: Fibronectin fragments cause chondrolysis of bovine articular cartilage slices in culture. J Biol Chem 267: 3597–3604, 1992
10. 10 Homandberg GA, Meyers R, Williams JM: Intraarticular injection of fibronectin fragments causes severe depletion of cartilage proteoglycans in vivo. J Rheumatol 20: 1378–1382, 1993
11. 11 Homandberg GA, Hui F: High concentrations of fibronectin fragments cause short‐term catabolic effects in cartilage tissue while lower concentrations cause continuous anabolic effects. Arch Biochem Biophys 311: 213–218, 1994
12. 12 Homandberg GA, Hui F: Association of proteoglycan degradation with catabolic cytokine and stromelysin release from cartilage cultured with fibronectin fragments. Arch Biochem Biophys 334: 325–331, 1996
13. 13 Homandberg GA, Hui F, Wen C, Kuettner KE, Williams JM: Hyaluronic acid suppresses fibronectin fragment mediated cartilage chondrolysis. I. In vitro. Osteoarthritis Cartilage 5: 309–319, 1997
14. 14 Homandberg GA, Hui F, Wen C, Purple C, Bewsey K, Koepp H, Huch K, Harris A: Fibronectin‐fragment‐induced cartilage chondrolysis is associated with release of catabolic cytokines. Biochem J 321: 751–757, 1997
15. 15 Iwata H: Pharmacologic and clinical aspects of intraarticular injection of hyaluronate. Clin Orthop 289: 285–291, 1993
16. 16 Kang Y, Koepp H, Cole AA, Kuettner KE, Homandberg GA: Cultured human ankle and knee cartilage differ in susceptibility to damage mediated by fibronectin fragments. J Orthop Res 16: 551–556, 1998
17. 17 Kopp S, Carlsson GE, Haraldson T, Wenneberg B: Long‐term effect of intraarticular injections of sodium hyaluronate and corticosteroid on temporomandibular joint arthritis. J Oral Maxillofac Surg 45: 929–935, 1987
18. 18 Lark MW, Gordy JT, Weidner JR, Ayala J, Kimura JH, Williams HR, Mumford RA, Flannery CR, Carlson SS, Iwata M, Sandy J: Cell‐mediated catabolism of aggrecan: evidence that cleavage at the “aggrecanase” site (Glu 373 ‐Ala 374) is a primary event in proteolysis of the interglobular domain. J Biol Chem 270: 2550–2556, 1995
19. 19 Lark MW, Williams H, Hoernner LA, Weidner J, Ayala JM, Harper CF, Christen A, Olszewski J, Konteatis Z, Webber R, Mumford RA: Quantitation of a matrix metalloproteinase‐generated aggrecan Gl fragment using a monospecific antipeptide serum. Biochem J 307: 245–252, 1995
20. 20 Lark MW, Bayne EK, Flanagan J, Harper CF, Hoerrner LA, Hutchinson NI, Singer II, Donatelli SA, Weidner JR, Williams HR, Mumford RA, Lohmander LS: Aggrecan degradation in human cartilage: evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints. J Clin Invest 100: 93–106, 1997
21. 21 Listrat V, Ayral X, Patarnello F, Bonvarlet J‐P, Simonnet J, Amor B, Dougados M: Arthroscopic evaluation of potential structure modifying activity of hyaluronan (Hyalgan) in osteoarthritis of the knee. Osteoarthritis Cartilage 5: 153–160, 1997
22. 22 Luyten FP, Hascall VC, Nissley SP, Morales TI, Reddi AH: Insulin‐like growth factors maintain steady‐state metabolism of proteoglycans in bovine articular cartilage explants. Arch Biochem Biophys 267: 416–425, 1988
23. 23 Morris EA, Wilcon S, Treadwell BV: Inhibition of interleukin 1‐mediated proteoglycan degradation in bovine articular cartilage explants by addition of sodium hyaluronate. Am J Vet Res 53: 1977–1982, 1992
24. 24 Pisko EJ, Turner RA, Soderstrom LP, Panetti M, Foster SL, Treadway WJ: Inhibition of neutrophil phagocytosis and enzyme release by hyaluronic acid. Clin Exp Rheumatol 1: 41–44, 1983
25. 25 Punzi L, Schiavon F, Cavasin F, Ramonda R, Gambari PF, Todesco S: The influence of intra‐articular hyaluronic acid on PGE2 and cAMP of synovial fluid. Clin Exp Rheumatol 7: 247–250, 1989
26. 26 Rosenberg L: Chemical basis for the histological use of safranin O in the study of articular cartilage. J Bone Joint Surg [Am] 53: 69–82, 1971
27. 27 Sato H, Takahashi T, Ide H, Fukushima T, Tabata M, Sekine F, Kobayashi K, Negishi M, Niwa Y: Antioxidant activity of synovial fluid, hyaluronic acid, and two subcomponents of hyaluronic acid: synovial fluid scavenging effect is enhanced in rheumatoid arthritis patients. Arthritis Rheum 31: 63–71, 1988
28. 28 Shichikawa K, Maeda A, Ogawa N: [Clinical evaluation of sodium hyaluronate in the treatment of osteoarthritis of the knee.] Ryumachi 23: 280–290, 1983
29. 29 Shimazu A, Jikko A, Iwamoto M, Koike T, Yan W, Okada Y, Shinmei M, Nakamura S, Kato Y: Effects of hyaluronic acid on the release of proteoglycan from the cell matrix in rabbit chondrocyte cultures in the presence and absence of cytokines. Arthritis Rheum 36: 247–253, 1993
30. 30 Williams JM, Plaza V, Hui F, Wen C, Kuettner KE, Homandberg GA: Hyaluronic acid suppresses fibronectin fragment mediated cartilage chondrolysis. II. In vivo. Osteoarthritis Cartilage 5: 235–240, 1997
31. 31 Xie D, Homandberg GA: Fibronectin fragments bind to and penetrate cartilage tissue resulting in proteinase expression and cartilage damage. Biochim Biophys Acta 1182: 189–196, 1993
32. 32 Xie D, Hui F, Homandberg GA: Fibronectin fragments alter matrix protein synthesis in cartilage tissue cultured in vitro. Arch Biochem Biophys 307: 110–118, 1993
33. 33 Xie DL, Hui F, Meyers R, Homandberg GA: Cartilage chondrolysis by fibronectin fragments is associated with release of several proteinases: stromelysin plays a major role in chondrolysis. Arch Biochem Biophys 311: 205–212, 1994